Report Ocean conducted research on the global Drug Discovery Informatics market, some important discoveries were made. First, the market is expanding steadily, and over the coming years, demand is expected to rise. Second, there is a lot of market competition, yet only a few major businesses control the sector. Last but not least, there are numerous chances for market innovation and improvement, notably in terms of product offerings and marketing tactics.
The drug discovery informatics market size is expected to reach USD 5.38 billion by 2027. Report Ocean presents a new report on drug discovery informatics market size, share, growth, industry trends, and forecast 2027, covering various industry elements and growth trends helpful for predicting the market’s future.
Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC178
Drug Discovery Informatics Market Report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
In 2020, the sequence analysis market segment accounted for the largest share and is likely to register a significant market growth over the study period. For sequence analysis, bioinformatics tools play an important role. They are widely used for the development of in-proprietary databases of protein, nucleic acid, and other biomolecule sequences. With the rising application of informatics solutions, gene sequencing is done through the identification of proteins and genes, which could further help in the development of potential drugs.
Basic drug discovery requires the involvement of different sets of databases, sequence analysis tools, such as BLAST, FASTA, and CLUSTALW. Moreover, the introduction of new products and software tools with higher computing capabilities are further contributing to the segment’s market growth. In this line, in July 2019, Certara introduced its new version of D360, a drug discovery platform. The platform enabled analysis, representation, alignment of the small sections of peptides.
The molecular modeling market segment is projected to witness a lucrative market growth over the study period. The technique is gaining popularity, owing to its wide applicability in the drug discovery process. Such tools are mostly used for the simulation of small molecules to predict their behavior at the molecular level. Moreover, the technique is also able to accelerate cost-efficiency in the drug discovery process.
Moreover, accelerated COVID-19 drug discovery programs across the globe are further favoring the market growth. It helps in providing fast-track services, where scientists could perform virtual screening via drug from Drug Bank, to target viral proteins and human ACE2 receptors. Such studies were also based on the in-silico tools to screen small molecules which have the potential to counter COVID-19.
Request Full Report :-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC178
Similarly, companies in the marketplace are introducing services supporting or speeding up the drug development process. In this line, in June 2020, IBM visual molecular explorer platform was used to segregate a set of molecules targeting COVID-19. This is the open-source sharable AI-enabled platform involved in the initial screening of potential drug candidates.
Major Players:
Market participants in the industry include Certara, Infosys Ltd., Albany Molecular Research Inc., Charles River Laboratories, Boehringer Ingelheim, Collaborative Drug Discovery, Jubilant Biosys, Selvita, Novo Informatics, Eurofins DiscoverX Products, ChemAxon Ltd., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.
Drug Discovery Informatics, Services Outlook
Clinical Trial Data Management
Docking
Molecular Modeling
Sequence Analysis Platforms
Other Services
Drug Discovery Informatics, Workflow Outlook
Discovery Informatics
Identification, Validation, & Assay Development Informatics
Lead Generation
Development Informatics
Lead Optimization
FHD Preparation
Phase IA
Phase IB/2
Drug Discovery Informatics, Mode Outlook
Outsourced
In-house
Get a Sample PDF copy of the report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC178
Drug Discovery Informatics, by Regional Outlook
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Central & South America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
What are the aspects of this report that relate to regional analysis?
The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC178
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean:
Email:sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)
Website:https://www.reportocean.com/